Novel human coronavirus infection: Difference between revisions
m Changes made per Mahshid's request |
|||
| (90 intermediate revisions by 3 users not shown) | |||
| Line 9: | Line 9: | ||
| genus = '''''Coronavirus''''' | | genus = '''''Coronavirus''''' | ||
}} | }} | ||
{{ | {{Novel human coronavirus infection}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{ADI}} | ||
{{SK}} Human betacoronavirus 2c EMC/2012; novel coronavirus | |||
==[[Novel human coronavirus infection overview|Overview]]== | |||
==[[Novel human coronavirus infection historical perspective|Historical Perspective]]== | |||
==[[Novel human coronavirus infection classification|Classification]]== | |||
==[[Novel human coronavirus infection pathophysiology|Pathophysiology]]== | |||
==[[Novel human coronavirus infection causes|Causes]]== | |||
==[[Novel human coronavirus infection differential diagnosis|Differentiating Novel Human Coronavirus Infection from other Diseases]]== | |||
==[[Novel human coronavirus infection epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Novel human coronavirus infection risk factors|Risk Factors]]== | |||
==[[Novel human coronavirus infection screening|Screening]]== | |||
==[[Novel human coronavirus infection natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Novel human coronavirus infection case definitions|Case Definitions]] | [[Novel human coronavirus infection history and symptoms|History and Symptoms]] | [[Novel human coronavirus infection physical examination|Physical Examination]] | [[Novel human coronavirus infection laboratory findings|Laboratory Findings]] | [[Novel human coronavirus infection chest x ray|Chest X Ray]] | [[Novel human coronavirus infection other imaging findings|Other Imaging Findings]] | [[Novel human coronavirus infection other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Novel human coronavirus infection medical therapy|Medical Therapy]] | [[Novel human coronavirus infection primary prevention|Primary Prevention]] | [[Novel human coronavirus infection secondary prevention|Secondary Prevention]] | [[Novel human coronavirus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Novel human coronavirus infection future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Novel human coronavirus infection case study one|Case #1]] | |||
==Related Chapters== | |||
* [[SARS]] | |||
* [[Coronavirus]] | |||
==External Links== | |||
* [http://www.who.int/csr/disease/coronavirus_infections/faq_dec12/en/index.html WHO FAQ Sheet] | |||
* [http://www.cdc.gov/coronavirus/ncv/case-def.html#guidance CDC Case Definition Guide] | |||
* [http://www.cdc.gov/coronavirus/ncv/index.html CDC Fact Sheet] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[category:disease]] | |||
[[category:virology]] | |||
Latest revision as of 18:13, 18 September 2017
| Coronavirus | ||||||||
|---|---|---|---|---|---|---|---|---|
 | ||||||||
| Virus classification | ||||||||
|
|
Novel Human Coronavirus Infection Microchapters |
|
Differentiating Novel Human Coronavirus Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Novel human coronavirus infection On the Web |
|
American Roentgen Ray Society Images of Novel human coronavirus infection |
|
Directions to Hospitals Treating Novel human coronavirus infection |
|
Risk calculators and risk factors for Novel human coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Synonyms and keywords: Human betacoronavirus 2c EMC/2012; novel coronavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Case Definitions | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies